Gilder Gagnon Howe & Co’s NewAmsterdam Pharma NAMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-29,569
| Closed | -$605K | – | 249 |
|
|
2025
Q1 | $605K | Sell |
29,569
-302
| -1% | -$6.18K | 0.01% | 205 |
|
|
2024
Q4 | $768K | Buy |
29,871
+5,949
| +25% | +$153K | 0.01% | 221 |
|
|
2024
Q3 | $397K | Sell |
23,922
-463
| -2% | -$7.69K | ﹤0.01% | 238 |
|
|
2024
Q2 | $468K | Sell |
24,385
-81
| -0.3% | -$1.56K | 0.01% | 235 |
|
|
2024
Q1 | $579K | Buy |
+24,466
| New | +$579K | 0.01% | 237 |
|